Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder

Summary

The purpose of this study is to determine the effects of suvorexant (SUVO), on sleep, stress, and drug craving during early abstinence from stimulants and to determine the effects of treatment (SUVO vs. treatment as usual (TAU)) on post-treatment (Days 13-30) residential program length of stay (LOS) and completion rate.

Timeline

Start

2024-07-25

Primary completion

2027-01-30

Completion

2027-01-30

Drugs

Indications